salicylaldoxime has been researched along with Endometrial Neoplasms in 1 studies
*Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertini, S; Carlson, KE; Granchi, C; Gunther, JR; Katzenellenbogen, JA; Macchia, M; Marchitiello, T; Martinelli, A; Minutolo, F; Prota, G; Rapposelli, S; Tuccinardi, T | 1 |
1 other study(ies) available for salicylaldoxime and Endometrial Neoplasms
| Article | Year |
|---|---|
Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
Topics: Computer Simulation; Endometrial Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Ligands; Models, Molecular; Oximes; Structure-Activity Relationship; Transcriptional Activation; Tumor Cells, Cultured | 2009 |